↓ Skip to main content

4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation

Overview of attention for article published in Frontiers in immunology, April 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
5 X users

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation
Published in
Frontiers in immunology, April 2020
DOI 10.3389/fimmu.2020.00577
Pubmed ID
Authors

Qiu-xia Qu, Xin-yun Zhu, Wen-wen Du, Hong-bin Wang, Yu Shen, Yi-bei Zhu, Cheng Chen

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 41%
Student > Master 5 15%
Student > Ph. D. Student 4 12%
Other 2 6%
Student > Bachelor 2 6%
Other 1 3%
Unknown 6 18%
Readers by discipline Count As %
Immunology and Microbiology 13 38%
Biochemistry, Genetics and Molecular Biology 8 24%
Medicine and Dentistry 3 9%
Agricultural and Biological Sciences 2 6%
Psychology 1 3%
Other 1 3%
Unknown 6 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2020.
All research outputs
#14,267,034
of 25,387,668 outputs
Outputs from Frontiers in immunology
#11,319
of 31,539 outputs
Outputs of similar age
#190,649
of 405,647 outputs
Outputs of similar age from Frontiers in immunology
#296
of 640 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,539 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 405,647 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 640 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.